Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
LEE6500 | Scientific Research Methods and Ethics | 3+0+ | 9 | Compulsory |
The nature and development process of scientific knowledge, methods and methodological principles in social sciences, some basic concepts related to scientific research methods, quantitative and qualitative data collection and analysis techniques, ethical rules to be applied in scientific research and citation formats and techniques in accordance with ethical rules. |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6207 | Individualized Treatment in Cancer | 2+0+0 | 6 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6104 | Seminar | 1+0+0 | 10 | Compulsory |
Making a presentation on a thesis topic |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6202 | Proficiency Exam Preparation Course | 0+0+0 | 20 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6204 | Thesis Proposal | 0+0+ | 30 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6301 | THESIS 1 | 0+0+0 | 30 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6302 | THESIS 2 | 0+0+0 | 30 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6401 | THESIS 3 | 0+0+0 | 30 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS | Compulsory/Elective |
MONK6402 | THESIS 4 | 0+0+0 | 30 | Compulsory |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6004 | Cancer Biochemistry | 3+0+0 | 8 |
Biochemical markers of cancer, biochemical changes occurring in the process of cancerization, the relationship of metabolic processes with cancer. |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6005 | Omix Technologies in Molecular Oncology | 3+0+0 | 8 |
Structural and functional research using Genome, Transcriptome, Proteome, Metabolome, Metagenome and Biomarker Concepts and OMIKS Technologies. |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6006 | Tumor Microenvironment | 3+0+0 | 8 |
Tumor microenvironment cells and components, tumor microenvironment molecular targets and clinical uses |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6007 | Cancer Stem Cell Biology | 3+0+0 | 8 |
Cancer stem cell hypothesis, hallmarks of cancer stem cells, signaling pathways, drug resistance, treatment approach, clinical significance |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6008 | Cell Death and Cancer | 2+2+0 | 8 |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6013 | Metabolic Targets in Cancer | 3+0+0 | 8 |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6015 | Advanced Cancer Bioinformatics | 3+0+ | 8 |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6016 | Signaling and Therapeutic Targets | 2+0+ | 8 |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6115 | Scientific Research Methods and Ethics | 3+0+0 | 8 |
Scientific Research Designs Hypothesising Keeping Scientific Records Presentation of Data Scientific Report Writing Academic Publishing and Indexing Publication Ethics |
Course Code | Course Name | (T+A+L) | ECTS |
MONK6205 | Tumor Immunology | 2+0+0 | 8 |
Basic biological concepts in tumor immunology; cellular and humoral immune response against tumors; cells in the tumor microenvironment and their effects; tumor antigens, immune surveillance and immune editing of tumor; escape mechanisms of the tumor from the immune system; angiogenesis, adhesion molecules and apoptosis mechanisms; immunotherapies as well as targeted therapies in cancer. |
Course Code | Course Name | (T+A+L) | ECTS |
TGY6013 | Epigenetics | 3+0+0 | 8 |
Epigenetics: The New Science of Genetics, Mechanisms of DNA Methylation, Mechanisms of Histone Modifications, The Epigenetics of Non-coding RNA, Analysis of Gene-specific DNA Methylation/ Methods for Assessing Genome-wide DNA Methylation, DNA Hypomethylation in Cancer, Altered Histone Modifications in Cancer, Gene Regulation During Tumorigenesis, Epigenetic Regulation of miRNAs in Cancer, Epigenetic Regulation of miRNAs in Cancer, Epigenetic Changes During Cell Transformation, Epigenetic Reprogramming of Mesenchymal Stem Cells, Epigenetic Targeting Therapies to Overcome |